SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from BOLLINGER INNOVATIONS, INC. (BINI) (CIK 0001499961) (BINI) — Oct 19, 2015

BOLLINGER INNOVATIONS, INC. (BINI) (CIK 0001499961)
Date: Oct. 19, 2015 · CIK: 0001499961 · Accession: 0001144204-15-059961

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-34887

Date
October 19, 2015
Author
/s/ Jonathan New
Form
CORRESP
Company
BOLLINGER INNOVATIONS, INC. (BINI) (CIK 0001499961)

Letter

Division of Corporation Finance Attention: Matthew Crispino, Attorney-Advisor Preliminary Proxy Statement on Schedule 14A Filed October 8, 2015 File No. 001-34887

Re: Net Element, Inc.

Dear Mr. Crispino and Mr. Kauten:

This letter is on behalf of Net Element, Inc. (the “Company,” “we,” “our” or “us”) in response to the letter from the staff (the “Staff”) of the Division of Corporation Finance of the United States Securities and Exchange Commission (the “Commission”), dated October 16, 2015, containing comments with respect to the Company’s Preliminary Proxy Statement on Schedule 14A that was filed on EDGAR on October 8, 2015 (the “Proxy Statement”).

For convenience of reference, we have set forth the Staff’s comments in bold below, with the Company’s response following each comment.

Proposal 1 – Approval of an amendment to the Company’s amended and restated certificate of incorporation to effectuate the reverse stock split, page 5

1. We note your disclosure that the number of shares available for future issuance will increase as a result of the reverse stock split. In your response letter, please tell us whether you presently have any plans, proposals or arrangements to issue any of the newly available authorized shares of common stock for any purpose, including future acquisitions and/or financings. If you do not, please revise your disclosure to state that you have no plans, proposals, or arrangements, written or otherwise, at this time to issue any of the newly available authorized shares of common stock.

The Company does not presently have any plans, proposals or arrangements to issue any of such newly available authorized shares of common stock for any purpose, including future acquisitions and/or financings. In response to the Staff’s comment, the Company has added a sentence on page 7 of the Proxy Statement to this effect.

2. To facilitate understanding, please disclose in tabular format the number of shares of common stock currently authorized, issued and outstanding, reserved for issuance, and authorized but unissued, and the number of shares in those same categories after giving effect to the reverse stock split at representative intervals within the specified range. Please also include the percentage of the authorized shares of common stock available for issuance both before and after the reverse stock split.

In response to the Staff’s comment, the Company has added the following paragraph and table on page 11 of the Proxy Statement:

The table below sets forth, as of the Record Date and for illustrative purposes only, certain approximated effects of potential Reverse Stock Split ratios between 1-for-10 and 1-for-30 on our Common Stock, inclusive (without giving effect to the treatment of fractional shares). The percentages for each line item in the table represent the percentage of the total number of authorized shares of Common Stock both prior to and after giving effect to the Reverse Stock Split and the assumed ratios.

Prior to

Reverse Stock Split

After Reverse Stock Split Assuming Certain Ratios

% 1-for-10 % 1-for-20 % 1-for-30 %

Number of Shares Authorized 300,000,000 100% 300,000,000 100% 300,000,000 100% 300,000,000 100%

Number of Shares Issued and Outstanding 77,664,163 25.9% 7,766,417 2.6% 3,883,209 1.3% 2,588,806 0.9%

Number of Shares Reserved for Issuance 53,798,626 17.9% 17,101,479 5.7% 15,062,748 5.0% 14,383,172 4.8%

Number of Shares Authorized and Unissued 222,335,837 74.1% 292,233,583 97.4% 296,116,791 98.7% 297,411,194 99.1%

Proposal 2 – Approval of the Issuance of Common Stock to Certain Directors and Officers of the Company Pursuant to the Letter Agreement, Including Upon Exercise of Certain Options, page 12

3. Please substantially revise this proposal to include a plain language description of the material terms of your agreement with officers and directors of your company to issue restricted common stock and options to purchase restricted common stock. In revising your disclosure, to the extent possible, please eliminate legal jargon, multiple parenthetical phrases and embedded lists, which make the disclosure unnecessarily dense and difficult to understand. In addition, please clarify the consequences to the company with respect to the issuance of the restricted shares and options should you fail to obtain shareholder approval of this proposal. In this regard, please specifically clarify the relationship between a vote against this proposal and adjustments to the purchase price for the shares.

In response to the Staff’s comment, the Company has revised the description of Proposal 2 to include a plain language description of the material terms of the Company’s agreement with its officers and directors to issue restricted common stock and options to purchase restricted common stock. In addition, the Company has clarified the disclosure as requested by the Staff in this comment.

* * *

In connection with responding to the Staff’s comments, and as requested by the Staff, we acknowledge the following:

· the Company is responsible for the adequacy and accuracy of the disclosure in the filing;

· Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and

· the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If you have any additional questions or comments, please feel free to contact me directly at 305.588.0122 or Serge V. Pavluk of Snell & Wilmer L.L.P. at 714.427.7442.

Sincerely,
/s/ Jonathan New

Show Raw Text
CORRESP
1
filename1.htm

October 19, 2015

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

    Attention:
    Matthew Crispino, Attorney-Advisor

    Jeff Kauten, Attorney-Advisor

 Re: Net Element, Inc.

Preliminary Proxy Statement on Schedule 14A

Filed October 8, 2015

File No. 001-34887

Dear Mr. Crispino and Mr. Kauten:

This letter is on behalf
of Net Element, Inc. (the “Company,” “we,” “our” or “us”) in response to the letter
from the staff (the “Staff”) of the Division of Corporation Finance of the United States Securities and Exchange Commission
(the “Commission”), dated October 16, 2015, containing comments with respect to the Company’s Preliminary Proxy
Statement on Schedule 14A that was filed on EDGAR on October 8, 2015 (the “Proxy Statement”).

For convenience of
reference, we have set forth the Staff’s comments in bold below, with the Company’s response following each comment.

Proposal 1 – Approval of an amendment
to the Company’s amended and restated certificate of incorporation to effectuate the reverse stock split, page 5

1.	We note your
disclosure that the number of shares available for future issuance will increase as a result of the reverse stock split. In your
response letter, please tell us whether you presently have any plans, proposals or arrangements to issue any of the newly available
authorized shares of common stock for any purpose, including future acquisitions and/or financings. If you do not, please revise
your disclosure to state that you have no plans, proposals, or arrangements, written or otherwise, at this time to issue any of
the newly available authorized shares of common stock.

The Company does not
presently have any plans, proposals or arrangements to issue any of such newly available authorized shares of common stock for
any purpose, including future acquisitions and/or financings. In response to the Staff’s comment, the Company has added a
sentence on page 7 of the Proxy Statement to this effect.

      1

2.	To facilitate
understanding, please disclose in tabular format the number of shares of common stock currently authorized, issued and outstanding,
reserved for issuance, and authorized but unissued, and the number of shares in those same categories after giving effect to the
reverse stock split at representative intervals within the specified range. Please also include the percentage of the authorized
shares of common stock available for issuance both before and after the reverse stock split.

In response to the
Staff’s comment, the Company has added the following paragraph and table on page 11 of the Proxy Statement:

The table below sets forth, as
of the Record Date and for illustrative purposes only, certain approximated effects of potential Reverse Stock Split ratios between
1-for-10 and 1-for-30 on our Common Stock, inclusive (without giving effect to the treatment of fractional shares). The percentages
for each line item in the table represent the percentage of the total number of authorized shares of Common Stock both prior to
and after giving effect to the Reverse Stock Split and the assumed ratios.

    Prior to

 Reverse Stock Split

    After Reverse Stock Split Assuming Certain Ratios

    %
    1-for-10
    %
    1-for-20
    %
    1-for-30
    %

    Number of Shares Authorized
      300,000,000
      100%
      300,000,000
      100%
      300,000,000
      100%
      300,000,000
      100%

    Number of Shares Issued and Outstanding
      77,664,163
      25.9%
      7,766,417
      2.6%
      3,883,209
      1.3%
      2,588,806
      0.9%

    Number of Shares Reserved for Issuance
      53,798,626
      17.9%
      17,101,479
      5.7%
      15,062,748
      5.0%
      14,383,172
      4.8%

    Number of Shares Authorized and Unissued
      222,335,837
      74.1%
      292,233,583
      97.4%
      296,116,791
      98.7%
      297,411,194
      99.1%

Proposal 2 – Approval of the Issuance
of Common Stock to Certain Directors and Officers of the Company Pursuant to the Letter Agreement, Including Upon Exercise of Certain
Options, page 12

3. 	Please substantially
revise this proposal to include a plain language description of the material terms of your agreement with officers and directors
of your company to issue restricted common stock and options to purchase restricted common stock. In revising your disclosure,
to the extent possible, please eliminate legal jargon, multiple parenthetical phrases and embedded lists, which make the disclosure
unnecessarily dense and difficult to understand. In addition, please clarify the consequences to the company with respect to the
issuance of the restricted shares and options should you fail to obtain shareholder approval of this proposal. In this regard,
please specifically clarify the relationship between a vote against this proposal and adjustments to the purchase price for the
shares.

      2

In response to the Staff’s comment,
the Company has revised the description of Proposal 2 to include a plain language description of the material terms of the Company’s
agreement with its officers and directors to issue restricted common stock and options to purchase restricted common stock. In
addition, the Company has clarified the disclosure as requested by the Staff in this comment.

* * *

In connection with responding to the Staff’s
comments, and as requested by the Staff, we acknowledge the following:

 · the Company is responsible for the adequacy and accuracy of the disclosure in the filing;

 · Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action
with respect to the filing; and

 · the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.

If you have any additional questions or
comments, please feel free to contact me directly at 305.588.0122 or Serge V. Pavluk of Snell & Wilmer L.L.P. at 714.427.7442.

Sincerely,

/s/ Jonathan New

Jonathan New

Chief Financial Officer

Net Element, Inc.

      3